JP Morgan Initiates Albany Molecular Research At Overweight

Analysts at JP Morgan initiated coverage on shares of Albany Molecular Research

with a Overweight rating. The target price for Albany Molecular Research is set to $25. Albany Molecular Research shares have jumped 74.22% over the past 52 weeks, while the S&P 500 index has surged 19.73% in the same period. Albany Molecular Research's shares gained 3.44% to close at $20.14 yesterday.